Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Incyte Corporation

Incyte Corporation

INCY · NASDAQ
INCY · NASDAQ

Next Earnings: 05 May 2026

97.58
USD-0.09-0.09%

Latest News

    @MarketRebels
    MarketRebels

    STARTS NOW! Rebel's Edge 🏴‍☠️ 1pm Line up: Headline retail sales rose 0.2% #Copper up 19% YTD STOCKS $INCY $GES $AFRM $SAIC 🏈SPORTS: Brackets14 teams from the SEC!!! #NFL: Cinci making huge moves, problem is Bengals paying wrong players. 🚨 Record deal: Texans All-Pro CB Derek… https://t.co/lesaWFlCXr https://t.co/KVrFOmqwso

      SeekingAlpha

      Incyte gains amid takeover speculation

        SeekingAlpha

        Incyte seesaws on report of potential Merck takeover interest

          @Reuters
          Reuters

          FDA approves Incyte's treatment for chronic graft-versus-host disease https://t.co/UVkkA9nPRS https://t.co/yNUiXVa1fx

            SeekingAlpha

            Incyte to acquire immune-focused drug developer Escient

              SeekingAlpha

              Incyte buys global rights for tafasitamab from MorphoSys

              Hold

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              97.22USD
              99.42USD

              52 Week Range

              56.13USD
              112.29USD

              Market Cap

              19.02BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US45337C1027

              CUSIP

              45337C102

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              15.24

              PEG Ratio

              0.35

              Book Value

              26.04

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              6.41

              Wall Street Target Price

              107.27

              EPS Estimate Current Year

              7.41

              EPS Estimate Next Year

              8.65

              EPS Estimate Current Quarter

              1.9165

              EPS Estimate Next Quarter

              1.5679

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              5,141,241,856

              Gross Profit TTM

              2,718,960,128

              EBITDA

              1,439,769,984

              Profit Margin

              25.03%

              Return On Assets TTM

              13.57%

              Return On Equity TTM

              29.87%

              Revenue Per Share TTM

              26.338

              Qtly Revenue Growth YOY

              27.80%

              Diluted Eps TTM

              6.41

              Qtly Earnings Growth YOY

              43.60%

              Valuation

              Trailing PE

              15.24

              Forward PE

              12

              Price Sales TTM

              3.7815

              Price Book MRQ

              3.6811

              Enterprise Value Revenue

              3

              Enterprise Value EBITDA

              8

              Peers analysis

              • Be
                ONCBeiGene, Ltd.

                320.06

                3.30%
              • CSL Limited
                CMXHFCSL Limited

                101.17

                2.78%
              • UCB SA
                UCBJFUCB SA

                334.09

                2.62%
              • argenx NV ADR
                ARGXargenx NV ADR

                840.79

                1.45%
              • CSL Ltd
                CSLLYCSL Ltd

                24.77

                0.65%
              • argenx SE
                ARGNFargenx SE

                712.02

                0.00%
              • UCB SA ADR
                UCBJYUCB SA ADR

                159.38

                -1.76%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                335.46

                -1.11%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                443.18

                -0.24%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                754.40

                -0.15%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Incyte Corporation stock price today?

              What is Incyte Corporation stock ticker?

              Is INCY stock price going up?

              What is the analyst recommendation for INCY?

              What is INCY market cap?

              Does INCY release financial reports?

              When is INCY next earnings date?

              What were INCY Earnings for the last quarter?

              What was INCY Revenue for the last quarter?

              What was INCY Net Income for the last quarter?

              Does INCY pay dividends?

              How many employees does INCY have?

              What is INCY EBITDA?

              How to buy INCY stocks?

              Should I invest in INCY stock?